Springer Nature
Browse
12885_2018_4685_MOESM3_ESM.tiff (1.46 MB)

Additional file 3: of Gefitinib provides similar effectiveness and improved safety than erlotinib for east Asian populations with advanced non–small cell lung cancer: a meta-analysis

Download (1.46 MB)
figure
posted on 2018-08-02, 05:00 authored by Wenxiong Zhang, Yiping Wei, Dongliang Yu, Jianjun Xu, Jinhua Peng
Figure S3. Cumulative meta-analysis related to ORR associated with gefitinib versus erlotinib. (TIFF 1498 kb)

Funding

National Natural Science Foundation of China

History

Usage metrics

    BMC Cancer

    Categories

    Keywords

    GefitinibErlotinibNon-small cell lung cancerEast Asian populationsTargeted therapyMeta-analysis

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC